Showing results (11-20 of 16) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Cancer Cell|January 4, 2016
Long-Term ERK Inhibition in KRAS-Mutant Pancreatic Cancer Is Associated with MYC Degradation and Senescence-like Growth SuppressionTikvah K Hayes, Nicole F Neel, Chaoxin Hu, et al.Bioorganic & Medicinal Chemistry Letters|September 1, 2007
The discovery of 6-amino nicotinamides as potent and selective histone deacetylase inhibitorsChristopher L Hamblett, Joey L Methot, Dawn M Mampreian, et al.Cancer Research|February 11, 2010
MK-2461, a novel multitargeted kinase inhibitor, preferentially inhibits the activated c-Met receptorBo-Sheng Pan, Grace K Y Chan, Melissa Chenard, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Delayed and Prolonged Histone Hyperacetylation with a Selective HDAC1/HDAC2 InhibitorJoey L Methot, Dawn Mampreian Hoffman, David J Witter, et al.Journal of Medicinal Chemistry|February 6, 2013
Discovery of 1-[3-(1-methyl-1H-pyrazol-4-yl)-5-oxo-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-7-yl]-N-(pyridin-2-ylmethyl)methanesulfonamide (MK-8033): A Specific c-Met/Ron dual kinase inhibitor with preferential affinity for the activated state of c-MetAlan B Northrup, Matthew H Katcher, Michael D Altman, et al.Bioorganic & Medicinal Chemistry Letters|January 10, 2008
Exploration of the internal cavity of histone deacetylase (HDAC) with selective HDAC1/HDAC2 inhibitors (SHI-1:2)Joey L Methot, Prasun K Chakravarty, Melissa Chenard, et al.Pageof 2